Last reviewed · How we verify
NCT05520957
Early SARS-CoV-2 Tracheostomy
trial testing Tracheostomy in Tracheostomy in 17 participants. Completed in 31 January 2022.
31 January 2022
Quick facts
| Lead sponsor | Cantonal Hospital Zenica |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 17 |
| Start date | 1 January 2020 |
| Primary completion | 31 January 2022 |
| Estimated completion | 31 January 2022 |
| Sites | 1 location across Bosnia and Herzegovina |
Drugs / interventions tested
- Tracheostomy
Conditions studied
- Tracheostomy — all drugs for Tracheostomy →
- Characteristics Disease — all drugs for Characteristics Disease →
- Metabolic Disturbance — all drugs for Metabolic Disturbance →
Sponsor
Cantonal Hospital Zenica
Who can join
Adults 18 to 80, any sex, with Tracheostomy or Characteristics Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective of this case series was to evaluate the characteristics of early COVID-19 tracheostomy and its effect on laboratory parameters. A series of 17 patients with COVID-19undergo surgical tracheostomy in our intensive care unit. Demographic parameters, duration indicators, and laboratory parameters before and after tracheostomy were analyzed in patients. Of the 17 patients, 4 were men and 13 women with a mean age of 59 years. The average length of total hospitalization were 12 days, the length of stay in intensive care were 10 days, the length of endotracheal intubation were 9 days, with the seventh day of tracheotomy. Neurological and thyroid diseases and withdrawal had a statistically significant difference (p \<0.05), with laboratory parameters without statistically difference. Critically ill COVID-19 patients undergoing early tracheostomy has a lower possibility of weaning from mechanical ventilation, and early tracheostomy itself has no significant effect on renal parameters, lactate and D-Dimer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05520957
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Tracheostomy
Trials testing the same drug.
- NCT07404592 — Tracheostomy Practices in Adult Intensive Care Units: A Multicentre Study in Izmir · completed
- NCT06346210 — Optimal Timing for Tracheostomy in Invasively Mechanically Ventilated COVID-19 Patients · completed
- NCT05465837 — Comparison Between Early and Late Tracheostomy in Non-Covid and Covid · completed
- NCT04572438 — A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy · completed
Other recruiting trials for Tracheostomy
Currently open trials in the same condition.
- NCT07107243 — SV With TTPEE Measurement Predicts Upper Airway Patency in Prolonged Tracheostomy Patients · NA · recruiting
- NCT07121517 — "Airway Complications in Pediatric Patients With Tracheostomies: To What Extent Can Symptoms Identified by Caregivers or · recruiting
- NCT06893458 — Feeding Difficulties and Quality of Life in Children With Tracheal Cannula · recruiting
- NCT06375369 — Digital Health Pathway for Children With Medical Complexity Requiring Tracheostomy · NA · recruiting
- NCT06779877 — The Effect of Percutaneous Dilatational Tracheostomy on Intracranial Pressure · active not recruiting
Other Cantonal Hospital Zenica trials
Trials by the same sponsor.
- NCT07138053 — The Impact Opioid Free Anesthesia on Postoperative Pain Intensity and Stress Response After Open Gynecology Surgery · NA · active not recruiting
- NCT06242626 — Euthyroid Sick Syndrome in Septic Shock · completed
- NCT05270798 — Thyroid Hormone Supplementation in Patients With Septic Shock · Phase 2 · completed
- NCT05496816 — Coagulation Disturbances in COVID-19 Septic Patients · completed
- NCT05421962 — Analgosedation for Elective Colonoscopy · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05520957 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cantonal Hospital Zenica
- Last refreshed: 2 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05520957.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing